Home > Insider Trading > Filing (0001567619-20-013287)

Filing Details

Accession Number:: 0001567619-20-013287
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-07-14 21:56:56
Reporting Period:: 2020-07-06

Accepted Time:: 2020-07-14 21:56:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1509261	Rezolute Inc.	RZLT	Pharmaceutical Preparations (2834)	273440894

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1798101	Handok, Inc.	132, Teheran-Ro Gangman Gu Seoul M4 06235		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Shares	Acquisiton	2020-07-06	300,000	$0.10	91,600,933	No	4	P	Direct
Common Shares	Acquisiton	2020-07-07	45,100	$0.11	91,646,033	No	4	P	Direct
Common Shares	Acquisiton	2020-07-08	45,200	$0.12	91,691,233	No	4	P	Direct
Common Shares	Acquisiton	2020-07-09	133,804	$0.13	91,825,037	No	4	P	Direct
Common Shares	Acquisiton	2020-07-10	18,550	$0.13	91,843,587	No	4	P	Direct
Common Shares	Acquisiton	2020-07-13	100,000	$0.15	91,943,587	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 6, 2020.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.10 to $0.105, inclusive. The reporting person undertakes to provide to Rezolute, Inc., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2).
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.10 to $0.109, inclusive. The reporting person undertakes to provide to Rezolute, Inc., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (3).
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.12 to $0.121, inclusive. The reporting person undertakes to provide to Rezolute, Inc., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (4).
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.125 to $0.130, inclusive. The reporting person undertakes to provide to Rezolute, Inc., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (5).
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.143 to $0.155, inclusive. The reporting person undertakes to provide to Rezolute, Inc., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (6).